Evidence map›Paper›PMID 34322259›Full record

ArticleClinical case reports2021

Clinical outcomes of post-renal transplant patients with COVID-19 infection in the ICU: A single-center case series.

Nissar Shaikh, Mohamad Y Khatib, Mohammad A Alwraidat, Dore C Ananthegowda, Muftah Othman, Asra Aroos, Sagar B Jujjavarapu, Saptarshi Banerjee, Zishan Nasir, Ahmed S Mohamed and 3 more

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nissar ShaikhSurgical Intensive Care Department Hamad General Hospital (HGH) Hamad Medical Corporation (HMC) Doha Qatar.
Mohamad Y KhatibMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Mohammad A AlwraidatMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Dore C AnanthegowdaMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Muftah OthmanNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Asra AroosMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Sagar B JujjavarapuNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Saptarshi BanerjeeMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Zishan NasirNephrology Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Ahmed S MohamedMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.ORCID https://orcid.org/0000-0002-2107-5357
Moustafa S ElshafeiMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
Muna A AlmaslamaniCommunicable Diseases Center (CDC) Hamad Medical Corporation (HMC) Doha Qatar.
Abdulqadir J NashwanMedical Intensive Care Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.ORCID https://orcid.org/0000-0003-4845-4119

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most of the post-renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti-proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post-renal transplant patients with severe COVID-19 infection admitted to the intensive care unit.

Indexed as

acute kidney injuryCOVID‐19 infectionend‐stage renal diseasehypertensionimmunosuppressionrenal transplant

Identifiers

PMID34322259
PMCPMC8299096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.